We are live on
!
Find out more
ECM
Estabrook Capital Management Portfolio holdings
AUM
$685M
1-Year Est. Return
26.64%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+26.64%
3 Year Est. Return
+76.16%
5 Year Est. Return
+96.13%
10 Year Est. Return
+311.62%
AUM
$638M
AUM Growth
-$42.4M
(-6.2%)
Cap. Flow
-$78.7M
Cap. Flow
% of AUM
-12.33%
Top 10 Holdings %
Top 10 Hldgs %
32.07%
Holding
467
New
48
Increased
34
Reduced
137
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLY.PRA
GMAC Capital Trust I 8.125% Fixed Rate/Floating Rate Trust Preferred Securities, Series 2
ALLY.PRA
|
+$1.95M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45M |
| 3 |
ConocoPhillips
COP
|
+$790K |
| 4 |
BHI
Baker Hughes
BHI
|
+$734K |
| 5 |
The Mosaic Company
MOS
|
+$624K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$4.52M |
| 2 |
Medtronic
MDT
|
+$4.25M |
| 3 |
JPMorgan Chase
JPM
|
+$4.02M |
| 4 |
CVS Health
CVS
|
+$3.88M |
| 5 |
Microsoft
MSFT
|
+$2.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.77% |
| 2 | Industrials | 16.22% |
| 3 | Technology | 15.92% |
| 4 | Healthcare | 11.98% |
| 5 | Energy | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$317B
| $9.67M | 1.52% |
172,144
-27,198
| -14% | -$1.59M |
|
27
Chevron
CVX
$371B
| $9.56M | 1.5% |
81,201
-7,997
| -9% | -$871K |
|
28
Corning
GLW
$135B
| $9.41M | 1.48% |
387,920
-57,599
| -13% | -$1.37M |
|
29
SLB Ltd
SLB
$76.5B
| $8.72M | 1.37% |
103,864
-22,663
| -18% | -$1.86M |
|
30
FRP Holdings
FRPH
$407M
| $8.67M | 1.36% |
459,884
-4,010
| -0.9% | -$71.1K |
|
31
Duke Energy
DUK
$96.6B
| $8.27M | 1.3% |
106,537
-11,796
| -10% | -$903K |
|
32
AT&T
T
$162B
| $8.03M | 1.26% |
249,983
-52,877
| -17% | -$1.56M |
|
33
Norfolk Southern
NSC
$76.9B
| $7.35M | 1.15% |
68,049
-16,246
| -19% | -$1.64M |
|
34
3M
MMM
$93.2B
| $7.07M | 1.11% |
47,345
-3,021
| -6% | -$436K |
|
35
Procter & Gamble
PG
$342B
| $6.89M | 1.08% |
81,991
-15,119
| -16% | -$1.29M |
|
36
Target
TGT
$66.8B
| $6.74M | 1.06% |
93,326
-10,257
| -10% | -$742K |
|
37
UnitedHealth
UNH
$367B
| $5.95M | 0.93% |
37,148
-10,600
| -22% | -$1.58M |
|
38
Williams Companies
WMB
$87.8B
| $5.92M | 0.93% |
189,973
-11,333
| -6% | -$342K |
|
39
Amgen
AMGN
$219B
| $5.73M | 0.9% |
39,199
-10,956
| -22% | -$1.65M |
|
40
NextEra Energy
NEE
$176B
| $5.22M | 0.82% |
174,660
-53,520
| -23% | -$1.6M |
|
41
Canadian Pacific Kansas City
CP
$79.3B
| $4.95M | 0.78% |
173,220
-1,435
| -0.8% | -$42.4K |
|
42
Aflac
AFL
$64.5B
| $4.53M | 0.71% |
130,212
-1,698
| -1% | -$59.8K |
|
|
BNY
43
Bank of New York Mellon
BNY
$108B
| $4.51M | 0.71% |
95,249
+1,200
| +1% | +$54.1K |
|
44
Home Depot
HD
$349B
| $4.05M | 0.63% |
30,193
-7,882
| -21% | -$1.02M |
|
45
Bladex Inc
BLX
$2.17B
| $3.89M | 0.61% |
132,291
-41,072
| -24% | -$1.17M |
|
46
US Bancorp
USB
$99.4B
| $3.74M | 0.59% |
72,840
-2,572
| -3% | -$122K |
|
47
PepsiCo
PEP
$189B
| $3.39M | 0.53% |
32,367
-5,074
| -14% | -$531K |
|
48
Eaton
ETN
$174B
| $3.32M | 0.52% |
49,499
-1,903
| -4% | -$125K |
|
49
Northrop Grumman
NOC
$80.7B
| $3.25M | 0.51% |
13,979
-245
| -2% | -$57K |
|
50
RenaissanceRe
RNR
$13.4B
| $3.2M | 0.5% |
23,456
-962
| -4% | -$123K |
|
Similar funds
TWM
HCP
ABWM
DMC
PPI
NS
ACM
SAM
Estabrook Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Estabrook Capital Management held 467 positions worth $638M, down 6.2% from $681M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Estabrook Capital Management withdrew a net $78.7M in Q4 2016, closing 19 positions and reducing 137 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $64.4K position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.
Against the trend, Estabrook Capital Management opened a new position in AdvanSix worth $91.5K.
- Estabrook Capital Management's largest Q4 2016 buy was AdvanSix: 4,133 shares worth $91.5K.
- Estabrook Capital Management added most to GMAC Capital Trust I 8.125% Fixed Rate/Floating Rate Trust Preferred Securities, Series 2 in Q4 2016, an estimated $1.95M increase.
- Estabrook Capital Management's biggest Q4 2016 reduction was PNC Financial Services, cutting an estimated $4.52M.
- Estabrook Capital Management fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $64.4K.
- Estabrook Capital Management's ten largest holdings make up 32% of its $638M portfolio in Q4 2016.
- Estabrook Capital Management opened 48 new positions and closed 19 in Q4 2016.
- Estabrook Capital Management's portfolio value fell 6.2% quarter-over-quarter to $638M.
Based on Estabrook Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.